Literature DB >> 32966283

The COVID-19 pandemic should not jeopardize dengue control.

Marie-Marie Olive1, Thierry Baldet2, James Devillers3, Johanna Fite4, Marie-Claire Paty5, Christophe Paupy1, Philippe Quénel6, Elsa Quillery4, Jocelyn Raude7, Jean-Paul Stahl8, Marie Thiann-Bo-Morel9, David Roiz1.   

Abstract

The concurrent circulation of dengue and coronavirus disease 2019 (COVID-19) may produce many unfavourable outcomes-such as co-infections; delays in diagnosis, treatment, and mitigation measures; overwhelming of the healthcare system; underreporting of cases; deterioration in surveillance and control interventions; and exacerbation of social inequalities. Indeed, lockdown is greatly compromising the effectiveness of vector control, especially social mobilization campaigns and preventive insecticide spraying in private spaces (indoor and peridomestic spraying). Thus, failure to appropriately implement the full range of vector control interventions can lead to a reduction in their overall effectiveness and an increasing risk of vector-borne diseases circulating. Consequently, the health community and policy makers should develop proactive policies and allocate adequate resources to prevent and manage the resurgence of dengue and other vector-borne diseases in the new era of COVID-19.

Entities:  

Mesh:

Year:  2020        PMID: 32966283      PMCID: PMC7510977          DOI: 10.1371/journal.pntd.0008716

Source DB:  PubMed          Journal:  PLoS Negl Trop Dis        ISSN: 1935-2727


Viewpoints

The coronavirus disease 2019 (COVID-19) pandemic, caused by the emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is now a major health crisis. By mid July 2020, there had been about 14 million cases and more than 600,000 deaths worldwide, and there have been massive economic consequences and social disruption. While this global crisis rightly demands the world’s attention, many other infectious diseases are still on the rise and risk increasing further as the focus shifts away from them. This is the case with dengue fever, a viral disease transmitted by Aedes mosquitoes, whose incidence has increased dramatically over the past decade [1], with severe epidemics currently affecting Latin America, Asia, and the Indian Ocean [2-6]. Brazil, for example, is currently experiencing the largest ever dengue epidemic, with nearly 800,000 cases and 221 deaths between January and April 2020 [3,7] (Fig 1, panel A). Similarly, Southwest Indian Ocean islands, such as La Réunion and Mayotte (two French overseas departments), are experiencing unprecedented dengue outbreaks, with more than 30,000 cases reported on the islands since 2017 [5,6] (Fig 1, panel B). At the same time, other arboviruses also transmitted by Aedes mosquitoes, such as chikungunya, Zika, and yellow fever, continue to occur in many parts of the world [10], and temperate regions of the Northern Hemisphere (United States and Europe), which are particularly affected by the COVID-19 pandemic, are also threatened by autochthonous transmission of dengue, chikungunya, and Zika in areas where the vectors A. aegypti and/or A. albopictus are established [11].
Fig 1

Confirmed cases of COVID-19 and dengue in Brazil (Panel A) and the Southwest Indian Ocean islands (La Réunion and Mayotte; Panel B) [5–9].

COVID-19, coronavirus disease 2019.

Confirmed cases of COVID-19 and dengue in Brazil (Panel A) and the Southwest Indian Ocean islands (La Réunion and Mayotte; Panel B) [5–9].

COVID-19, coronavirus disease 2019. In April 2020, in a context of concurrent epidemics of dengue and COVID-19 in the French overseas departments, the French Ministry of Health tasked the French Agency for Food, Environmental and Occupational Health & Safety (ANSES) with setting up a multidisciplinary task force of experts to assess the impact of the COVID-19 pandemic and lockdown (imposed from 17 March to 11 May in France) on dengue surveillance and vector control interventions. Their report was recently published [12], and in this letter, the task force presents the results of its expert assessment and its recommendations to the global health community.

Considerations and recommendations

Concurrent circulation of COVID-19 and dengue can lead to a delay in diagnosis and may therefore negatively affect the management, care, and control interventions specific to each of the 2 diseases. Differential diagnosis is required because the 2 viral infections share certain clinical features, such as fever, fatigue, and headache [4,13-16]. In addition, concern has been raised over the discovery of cases of false-positive dengue serology in individuals with COVID-19 [17]. Confusion in diagnosis or in test results can have dramatic consequences not only for patients but also for public health control interventions (e.g., contact tracing in the case of COVID-19 and vector control in the case of dengue). Co-circulation of the 2 viruses in the same regions exacerbates the health risk because of the potentially critical consequences of both infections in terms of morbidity and mortality, especially in severe cases. Although co-infection of dengue and COVID-19 has so far been only sporadically documented in Thailand, Singapore, Mayotte, and La Réunion islands [16,18], it is raising serious concerns in countries affected by dengue outbreaks, particularly in Southeast Asia and South America [2–4, 13–20]. Healthcare services in many countries have already been disrupted or even overwhelmed by the COVID-19 pandemic, and co-occurrence of the 2 diseases often aggravates the situation. This is particularly worrying in regions where several dengue serotypes are co-circulating and where secondary or even tertiary infections have been recorded [5,7]. Epidemiological surveillance of dengue has also been detrimentally affected. In all the French overseas departments, there was a drop in declared notified dengue cases just after the start of the lockdown (epidemiological weeks 12–13, Fig 1, panel B), even though there had been a marked increase in the number of cases over the previous weeks [12]. Underreporting of dengue, notable for paucisymptomatic cases, can be attributed not only to lockdown and to difficulties in moving around, even for medical reasons, but also to public concern over the risk of being infected by COVID-19 in health facilities, the closure of some clinics, and disrupted access to diagnosis [12]. The COVID-19 pandemic also affects vector control of Aedes mosquitoes in drawing attention and collective mobilization away from dengue and other arboviral diseases and their vector mosquitoes. In the wake of the COVID-19 crisis and lockdown, vector control interventions were scaled down in all the French overseas departments, social mobilization campaigns were put on hold, and preventive insecticide spraying was curtailed, especially in private spaces (indoor and peridomestic spraying) [12]. In the absence of vaccines and therapeutic treatment, the prevention and control of dengue and other Aedes-borne viral diseases continues to rely heavily on controlling mosquito vector populations or on interrupting human–vector contact through integrated, sustainable, synergic, and proactive vector management [1,21]. Failure to appropriately implement the full range of vector control interventions can reduce their overall effectiveness [1,21]. In fact, many of the interventions that are an essential part of an effective dengue control programme targeting private properties—such as indoor residual spraying, door-to-door campaigning, source reduction, and peridomestic residual spraying (Table 1)—are at odds with the guidelines for COVID-19 prevention and lockdown, simply because they require or may entail close contact between the vector control teams and the resident population. As such, interventions forming the core of efficient dengue control are expected to be significantly scaled down in many areas of the world where they are commonly carried out [1,12]. In an effort to fill this gap, while acknowledging the effectiveness of social mobilization in the control and prevention of Aedes-borne diseases [1,21], we consider it is crucial to strengthen communication for social mobilization against these diseases using digital communication tools and social networks jointly with the dissemination of information concerning COVID-19 (e.g., eliminating mosquito breeding sites while staying home), and to adapt existing guidelines to meet the current situation (Table 1) [19, 20]. Thus, vector control workers should use personal protective equipment and physical distancing while carrying out any vector control interventions, including those targeting larvae and adult mosquitoes, as well as community-based control measures (Table 1) [12,19,20]. In addition, local teams that know how to make information more effective in the field [20] could combine messages aimed at strengthening household and community participation in vector control measures with COVID-19 prevention and best practice messages [19,20]. Consequently, it is essential to reaffirm the crucial role of vector control staff, not only for dengue control measures but also to leverage community ownership and engagement in public health, and in particular to ensure the safety of these agents facing COVID-19, so that they can guarantee the safety of populations confronted with dengue fever.
Table 1

Effectiveness, strength of evidence of vector control measures [1, 12], assessment of the risk of transmission of COVID-19 for vector control workers, and recommendation for maintaining vector control measures in compliance with COVID-19 prevention (table adapted from the task force report [12] and updated [19, 20]).

Vector control measuresEffectiveness [1,12,19]Strength of evidence [1, 12]Type of transmission risk of COVID-19Degree of transmission risk of COVID-19 assessed by the expert groupRecommendations
Interventions in public areas
Outdoor spatial spraying with vehicle mountedLowLowContact with colleague within vehicleLowOne person per vehicle or staggered seating and wearing masksVehicle ventilation (between each use)
Contact with fomites within vehicleLowA vehicle assigned to a given driver during the journeyHand washing (soap, hydroalcoholic gel)Regular cleaning of surfaces in contact with hands (e.g., door handles, steering wheel, gear lever, armrests, etc.)Establish a protocol for cleaning vehicles after each use
Outdoor spatial spraying with portable equipmentModerateLowContact with publicModeratePhysical distancing (>1 m)Wearing mask/protective visorReduction of contact time with people
Contact with fomitesLowHand washing (soap, hydroalcoholic gel)Wearing disposable gloves
Eliminating nonpermanent breeding sitesHighModerateContact with publicModeratePhysical distancing (>1 m)Wearing mask/protective visorReduction of contact time with peopleThe elimination of breeding sites must be carried out without any exchange or proximity with the resident(s) of the house visitedDuring lockdown, households should be encouraged to work together in and around their homes to get rid of stagnant water, reduce solid wastes, and ensure proper covering of all water storage containers
Contact with fomitesModerateHand washing (soap, hydroalcoholic gel)Wearing disposable gloves
LarvicidingHighModerateContact with publicModeratePhysical distancing (>1 m)Wearing mask/protective visorReduction of contact time with people
Contact with fomitesLowHand washing (soap, hydroalcoholic gel)Wearing disposable gloves
Interventions in private areas (houses)
Eliminating nonpermanent breeding sitesModerateLowContact with residentsHighPhysical distancing (>1 m)Wearing mask/protective visorReduction of contact time with peopleThe elimination of breeding sites must be carried out without any exchange or proximity with the resident(s) of the house visitedDuring lockdown, households should be encouraged to work together in and around their homes to get rid of stagnant water, reduce solid wastes, and ensure proper covering of all water storage containers
Contact with fomitesHighHand washing (soap, hydroalcoholic gel)Wearing disposable gloves
Intradomiciliar treatmentsHighHighContact with residentsHighPhysical distancing (>1 m)Wearing mask/protective visorReduction of contact time with people
Contact with fomitesHighHand washing (soap, hydroalcoholic gel)Wearing disposable gloves
Peridomiciliar treatmentsModerateModerateContact with residentsHighPhysical distancing (>1 m)Wearing mask/protective visorReduction of contact time with people
Contact with fomitesModerateHand washing (soap, hydroalcoholic gel)Wearing disposable gloves
Social mobilization
Social mobilization: door to doorHighHighContact with residentsHighPhysical distancing (>1 m)Wearing mask/protective visorReduction of contact time with peopleUnder the present situation, even during lockdown, households should be encouraged to work together in and around their homes to get rid of stagnant water, reduce solid wastes, and ensure proper covering of all water storage containers
Contact with fomitesModerateHand washing (soap, hydroalcoholic gel)Wearing disposable gloves
Social mobilization during event gathering peopleModerateLow to moderateContact with residentsHighThe organisation of this type of event must be considered in the light of COVID-19 epidemiological situationExcluded during lockdown and/or during COVID-19 high circulationIn areas where schools are reopened, special sessions should be devoted to awareness of COVID-19 and dengue prevention (including vector control measures)Organise the event outdoorPhysical distancing (>1 m)Wearing mask/protective visorReduction of contact time with peopleLimit the number of persons
Contact with fomitesHighHand washing (soap, hydroalcoholic gel)Wearing disposable gloves
Social mobilization (media, social networks, etc.)ModerateLow to moderateNo contactNullNo restrictionsJoint communication of prevention messages for COVID-19 and dengue prevention (including vector control measures)
Within work premises
Within the work premisesNANAContact with colleaguesHighPhysical distancing (>1 m)Shifting schedule offsetTeam partitioningLimiting team sizeLimiting time spent in premisesWearing mask/protective visor
Contact with fomitesHighHand washing (soap, hydroalcoholic gel)Ensure regular cleaning of the premises (handles, furniture, washbasins, etc.) and increase its frequency (adapt the cleaning protocol)

Abbreviations: COVID-19, coronavirus disease 2019; NA, not applicable

Abbreviations: COVID-19, coronavirus disease 2019; NA, not applicable The negative impact of the COVID-19 crisis on dengue surveillance and control is obvious in tropical areas affected by dengue epidemics, but the risk of local cases of dengue and other arboviruses in temperate regions is expected to be lower as travel restrictions limit the opportunities for viral importation. However, the risk is still there, as 14 dengue cases were imported into European France during the lockdown period from 17 March to 11 May 2020, despite the very low number of flights returning from dengue-affected areas [12]. The resumption, even partial, of air transport this summer will bring with it a risk of viraemic travellers returning from regions affected by these arboviruses during the vector season in Europe [11,12]. Neglecting early vector control intervention around imported cases may also increase the risk of autochthonous cases of arbovirus [11]. Finally, the adverse economic and social consequences could be aggravated by concurrent circulation of these diseases. Social inequalities in relation to dengue and other arboviruses, such as Zika, have been highlighted [22]. Similarly, it has recently emerged that the COVID-19 pandemic is exacerbating social inequalities, as has been shown in the French overseas departments, such as La Réunion and Mayotte, as well as in the US [23,24].

Conclusion

Public health systems are faced with the challenge of co-circulation of dengue and COVID-19 and the many detrimental outcomes—which include co-infections; delays in diagnosis, treatment, and mitigation measures; overwhelming of healthcare systems; underreporting of cases; deterioration of surveillance and vector control interventions; and exacerbation of social inequalities. If the effectiveness of vector control measures is compromised, this can have serious consequences for public health. We have therefore put forward a framework for dealing with these risks on a global level (Table 1) [12]. As highlighted earlier [19,20], we have drawn attention to the importance of maintaining and strengthening integrated management of mosquito-borne diseases—especially surveillance, vector control in private spaces (door-to-door campaigns, indoor and peridomestic sprayings) and social mobilization—during the COVID-19 pandemic, and to the importance of upgrading guidance to take into account the need to minimise workers and citizens being exposed to risk. Even as several countries are unlocked, there is wide concern over the possibility of a second wave of the COVID-19 epidemic, and a new (strict or partial) lockdown is underway in some regions [25]. Throughout the world, we are facing an imminent potential risk of arboviral diseases, such as dengue fever, chikungunya, Zika, and yellow fever, surging simultaneously due to a deterioration in surveillance and vector control and giving rise to a more severe situation than the COVID-19 pandemic alone. We urge the health community and policy makers to urgently develop proactive policies and allocate adequate resources to prevent and manage the resurgence of vector-borne diseases in the new era of COVID-19. More broadly, in the context of the risk of new emerging disease occurrence with high epidemic and pandemic potential, advance preparedness will be essential to maintain and strengthen vector-borne disease control activities.
  16 in total

1.  To alert coinfection of COVID-19 and dengue virus in developing countries in the dengue-endemic area.

Authors:  Di Wu; Jianyun Lu; Qun Liu; Xiaowei Ma; Weiyun He
Journal:  Infect Control Hosp Epidemiol       Date:  2020-05-04       Impact factor: 3.254

2.  COVID-19 and dengue fever: A dangerous combination for the health system in Brazil.

Authors:  Camila Lorenz; Thiago S Azevedo; Francisco Chiaravalloti-Neto
Journal:  Travel Med Infect Dis       Date:  2020-04-09       Impact factor: 6.211

Review 3.  Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis.

Authors:  Leigh R Bowman; Sarah Donegan; Philip J McCall
Journal:  PLoS Negl Trop Dis       Date:  2016-03-17

4.  Racial Capitalism: A Fundamental Cause of Novel Coronavirus (COVID-19) Pandemic Inequities in the United States.

Authors:  Whitney N Laster Pirtle
Journal:  Health Educ Behav       Date:  2020-04-26

5.  Co-infection of dengue and COVID-19: A case report.

Authors:  Morgane Verduyn; Nathalie Allou; Virgile Gazaille; Michel Andre; Tannvir Desroche; Marie-Christine Jaffar; Nicolas Traversier; Cecile Levin; Marie Lagrange-Xelot; Marie-Pierre Moiton; Stella Hoang
Journal:  PLoS Negl Trop Dis       Date:  2020-08-03

6.  From importation to autochthonous transmission: Drivers of chikungunya and dengue emergence in a temperate area.

Authors:  Frédéric Jourdain; David Roiz; Henriette de Valk; Harold Noël; Grégory L'Ambert; Florian Franke; Marie-Claire Paty; Anne Guinard; Jean-Claude Desenclos; Benjamin Roche
Journal:  PLoS Negl Trop Dis       Date:  2020-05-11

7.  COVID-19 in medical personnel: observation from Thailand.

Authors:  B Joob; V Wiwanitkit
Journal:  J Hosp Infect       Date:  2020-02-27       Impact factor: 3.926

8.  Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period.

Authors:  Stephen M Kissler; Christine Tedijanto; Yonatan H Grad; Marc Lipsitch; Edward Goldstein
Journal:  Science       Date:  2020-04-14       Impact factor: 47.728

9.  Covert COVID-19 and false-positive dengue serology in Singapore.

Authors:  Gabriel Yan; Chun Kiat Lee; Lawrence T M Lam; Benedict Yan; Ying Xian Chua; Anita Y N Lim; Kee Fong Phang; Guan Sen Kew; Hazel Teng; Chin Hong Ngai; Li Lin; Rui Min Foo; Surinder Pada; Lee Ching Ng; Paul Anantharajah Tambyah
Journal:  Lancet Infect Dis       Date:  2020-03-04       Impact factor: 25.071

10.  COVID-19 and dengue, co-epidemics in Ecuador and other countries in Latin America: Pushing strained health care systems over the edge.

Authors:  Juan-Carlos Navarro; Jazzmin Arrivillaga-Henríquez; José Salazar-Loor; Alfonso J Rodriguez-Morales
Journal:  Travel Med Infect Dis       Date:  2020-04-05       Impact factor: 6.211

View more
  13 in total

1.  The impact of the COVID-19 pandemic on rabies reemergence in Latin America: The case of Arequipa, Peru.

Authors:  Brinkley Raynor; Elvis W Díaz; Julianna Shinnick; Edith Zegarra; Ynes Monroy; Claudia Mena; Micaela De la Puente-León; Michael Z Levy; Ricardo Castillo-Neyra
Journal:  PLoS Negl Trop Dis       Date:  2021-05-21

2.  Web-based searching for abortion information during health emergencies: a case study of Brazil during the 2015/2016 Zika outbreak.

Authors:  Tiziana Leone; Ernestina Coast; Sonia Correa; Clare Wenham
Journal:  Sex Reprod Health Matters       Date:  2021-12

3.  Implications of the COVID-19 Lockdown on Dengue Transmission in Malaysia.

Authors:  Song-Quan Ong; Hamdan Ahmad; Ahmad Mohiddin Mohd Ngesom
Journal:  Infect Dis Rep       Date:  2021-02-05

4.  Measuring the effects of COVID-19-related disruption on dengue transmission in southeast Asia and Latin America: a statistical modelling study.

Authors:  Yuyang Chen; Naizhe Li; José Lourenço; Lin Wang; Bernard Cazelles; Lu Dong; Bingying Li; Yang Liu; Mark Jit; Nikos I Bosse; Sam Abbott; Raman Velayudhan; Annelies Wilder-Smith; Huaiyu Tian; Oliver J Brady
Journal:  Lancet Infect Dis       Date:  2022-03-02       Impact factor: 71.421

5.  Addressing the COVID-19 pandemic challenges for operational adaptations of a cluster randomized controlled trial on dengue vector control in Malaysia.

Authors:  Mitra Saadatian-Elahi; Neal Alexander; Tim Möhlmann; Farah Diana Ariffin; Frederic Schmitt; Jason H Richardson; Muriel Rabilloud; Nurulhusna Ab Hamid
Journal:  BMC Public Health       Date:  2022-04-06       Impact factor: 3.295

6.  Level of dengue preventive practices and associated factors in a Malaysian residential area during the COVID-19 pandemic: A cross-sectional study.

Authors:  Dina Nurfarahin Mashudi; Norliza Ahmad; Salmiah Mohd Said
Journal:  PLoS One       Date:  2022-04-29       Impact factor: 3.752

7.  Clinical and biochemical parameters of COVID-19 patients with prior or active dengue fever.

Authors:  Isabella Márcia Soares Nogueira Teotônio; Juliana Lott de Carvalho; Luiz Cláudio Castro; Nadjar Nitz; Luciana Hagström; Geraldo Gonçalves Rios; Maria de Fátima Rodrigues de Oliveira; Bruno Stéfano Lima Dallago; Mariana Hecht
Journal:  Acta Trop       Date:  2020-11-28       Impact factor: 3.222

8.  Dengue and COVID-19 infections in the ASEAN region: a concurrent outbreak of viral diseases.

Authors:  Lowilius Wiyono; Ian Christoper N Rocha; Trisha Denise D Cedeño; Adriana Viola Miranda; Don Eliseo Lucero-Prisno Iii
Journal:  Epidemiol Health       Date:  2021-09-16

9.  Molecular Characterization of Imported and Autochthonous Dengue in Northeastern Spain.

Authors:  Jessica Navero-Castillejos; Rosa Benitez; Nuria Torner; José Muñoz; Daniel Camprubí-Ferrer; Aida Peiró-Mestres; Elena Sulleiro; Aroa Silgado; Verónica Gonzalo; Teresa Falgueras; Izaskun Alejo-Cancho; Montserrat Roldán; Virginia Plasencia; Rosa Albarracin; Josefa Perez; Alexander Navarro; Ana Calderón; Rosa Rubio; Mireia Navarro; Miguel Micó; Jaume Llaberia; María Navarro; Josep Barrachina; Anna Vilamala; Carmina Martí; María Ángeles Pulido; María Paz Sanchez-Seco; Ana Vazquez; Ana Martínez; Mireia Jané; Miguel Julián Martínez
Journal:  Viruses       Date:  2021-09-23       Impact factor: 5.048

10.  SARS-CoV-2/DENV co-infection: a series of cases from the Federal District, Midwestern Brazil.

Authors:  Heidi Luise Schulte; José Diego Brito-Sousa; Marcus Vinicius Guimarães Lacerda; Luciana Ansaneli Naves; Eliana Teles de Gois; Mariana Sirimarco Fernandes; Valéria Paes Lima; Carlos Henrique Reis Esselin Rassi; Clara Correia de Siracusa; Lizandra Moura Paravidine Sasaki; Selma Regina Penha Silva Cerqueira; Cleandro Pires de Albuquerque; Ana Paula Monteiro Gomides Reis; Ciro Martins Gomes; Patricia Shu Kurizky; Licia Maria Henrique da Mota; Laila Salmen Espindola
Journal:  BMC Infect Dis       Date:  2021-07-31       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.